疑诊心肌病患者心脏MRI T1与T2参数成像的临床影响
本回顾性单中心研究纳入2017年1月至2019年10月疑诊心肌病并接受心脏MRI的1876例患者,比较核心方案联合T1、T2参数成像与单纯核心方案的诊断准确度、读片者诊断信心及后续心脏影像利用。联合参数成像提高了心肌炎、法布里病和淀粉样变性的诊断敏感度,并与较低的后续心脏影像检查利用率相关。
要点
- 疑诊心肌病时,核心方案联合T1、T2参数成像可提高心肌炎、法布里病和淀粉样变性的诊断敏感度。
- 联合参数成像使39%(174/450)患者的读片者诊断信心得到改善。
- 联合参数成像组47%的患者至少接受一次后续心脏影像检查,低于未联合组的55%(P = .01)。
核心结论
- 在疑诊心肌病患者中,心脏MRI联合T1和T2参数成像具有较高的诊断效用,并与较低的后续心脏影像检查利用率相关。
研究设计与样本
- 回顾性单中心研究,纳入2017年1月至2019年10月疑诊心肌病并接受心脏MRI的连续临床扫描1876例(平均年龄51岁±17[SD],男性1113例),其中751例(40%)仅行核心方案、1125例(60%)行核心方案联合T1和T2参数成像。
关键影像表现/征象
- 参数成像组中T1升高280例(25%),T2升高47例(4%)。
- 在诊断效用亚组(n = 450)中,核心方案联合T1和T2参数成像使174例(39%)患者的读片者诊断信心得到改善。
诊断标准与关键数值
- 联合参数成像与单纯核心方案相比,诊断心肌炎的敏感度为89%(31/35)vs 69%(24/35),P = .008。
- 联合参数成像与单纯核心方案相比,诊断法布里病的敏感度为93%(13/14)vs 50%(7/14),P = .01。
- 联合参数成像与单纯核心方案相比,诊断淀粉样变性的敏感度为100%(16/16)vs 63%(10/16),P = .01。
临床应用与阅片要点
- 在疑诊心肌病的常规心脏MRI中,联合T1和T2参数成像可提高心肌炎、法布里病和淀粉样变性的诊断敏感度并改善读片者诊断信心。
- 联合参数成像与较低的后续心脏影像检查利用率相关:联合组47%的患者至少接受一次后续心脏影像检查,未联合组为55%(P = .01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background There are limited data on the incremental value of parametric mapping compared with core cardiac MRI protocols for suspected cardiomyopathy in routine clinical practice. Purpose To evaluate the impact of cardiac MRI T1 and T2 mapping in routine clinical practice with respect to diagnostic accuracy, reader diagnostic confidence, and downstream cardiac imaging utilization. Materials and Methods In this retrospective single-center study, consecutive clinical cardiac MRI scans obtained with and without T1 and T2 mapping for evaluation of suspected cardiomyopathy between January 2017 and October 2019 were evaluated. Diagnostic accuracy and reader diagnostic confidence were evaluated in a random subset. Downstream cardiac imaging utilization was analyzed in patients with a minimum of 1 year of clinical follow-up ending before January 2020. Results A total of 1876 patients (mean age, 51 years ± 17 [SD]; 1113 men) were evaluated. Of these, 751 (40%) underwent cardiac MRI with the core protocol and 1125 (60%) with the core protocol plus T1 and T2 mapping. In the mapping group, T1 and T2 were high in 280 (25%) and 47 patients (4%), respectively. In the subset evaluated for diagnostic utility (n = 450), the addition of T1 and T2 maps to the core protocol resulted in an improvement in reader diagnostic confidence in 174 patients (39%). Diagnostic sensitivity was higher with the core protocol plus mapping compared with the core protocol alone for myocarditis (89% [31 of 35 patients] vs 69% [24 of 35]; P = .008), Fabry disease (93% [13 of 14 patients] vs 50% [seven of 14]; P = .01), and amyloidosis (100% [16 of 16 patients] vs 63% [10 of 16]; P = .01). In the subset evaluated for downstream imaging utilization (n = 903), 47% of patients with mapping had at least one subsequent cardiac imaging test compared with 55% of patients without mapping (P = .01). Conclusion In patients with suspected cardiomyopathy, cardiac MRI with T1 and T2 mapping had high diagnostic utility and was associated with lower downstream cardiac imaging utilization. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Jerosch-Herold and Coelho-Filho in this issue.
引用
- Warnica W, Al-Arnawoot A, Stanimirovic A, et al. Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy. Radiology. 2022. PMID: 35787201. doi:10.1148/radiol.220067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。